Profil
Robert J.
Weiskopf is currently the Chief Financial Officer at Stealth BioTherapeutics, Inc. He previously worked as the Finance Director at Authorize.
Net Holdings, Inc., the Chief Financial Officer & Treasurer at Aware, Inc. (Massachusetts), and the Treasurer, Chief Financial & Accounting Officer at ArQule, Inc. He also held the position of Chief Financial Officer at Stealth BioTherapeutics Corp.
until 2022.
Weiskopf received his undergraduate and graduate degrees from The Isenberg School of Management.
Aktive Positionen von Robert Weiskopf
| Unternehmen | Position | Beginn |
|---|---|---|
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Finanzdirektor/CFO | 01.09.2019 |
Ehemalige bekannte Positionen von Robert Weiskopf
| Unternehmen | Position | Ende |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Finanzdirektor/CFO | 30.09.2022 |
| ARQULE, INC. | Finanzdirektor/CFO | 29.03.2019 |
| AWARE, INC. | Finanzdirektor/CFO | 30.05.2006 |
Authorize.Net Holdings, Inc.
Authorize.Net Holdings, Inc. Data Processing ServicesTechnology Services Offers online payment processing and billing services | Finanzdirektor/CFO | 01.01.2004 |
Ausbildung von Robert Weiskopf
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Authorize.Net Holdings, Inc.
Authorize.Net Holdings, Inc. Data Processing ServicesTechnology Services Offers online payment processing and billing services | Technology Services |
Aware, Inc. (Massachusetts)
Aware, Inc. (Massachusetts) Packaged SoftwareTechnology Services Develops biometrics software | Technology Services |
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
The Isenberg School of Management
The Isenberg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
















